Sort
172,184 grants matching “inflammation”
Genetic Contribution to Graft and Patient Outcomes
$1,039,562University Of Pittsburgh At Pittsburgh · P50 · FY2004 · HL
Development of a Peptide-Drug Conjugate for Topically Treating the Viral Skin Disease Molluscum Contagiosum
$1,039,551Robert Paul Ricciardi · Fox Chase Chemical Diversity Center, Inc · R42 · FY2024 · AI
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
$1,038,958Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2023 · CA
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$1,038,805Massimo Gadina · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIH · FY2017 · AR
Etiological Studies of Gastric Carcinoma
$1,038,693Keith T Wilson · Vanderbilt University Medical Center · P01 · FY2017 · CA
Molecular mechanisms of resistance to TGF-beta signaling
$1,038,566Seong-Jin Kim · Basic Sciences · Z01 · FY2007 · CA
Extracellular vesicles as mediators and markers for aging
$1,038,467Yie Liu · National Institute On Aging · ZIA · FY2022 · AG
Signaling in the retina and retinal pigment epithelium
$1,038,271Thomas Redmond · National Eye Institute · ZIA · FY2019 · EY
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$1,038,121Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
Glaucoma Drainage Device and Endothelial Cell Density Loss Compare (DECLARE) Trial
$1,038,103Ying Han · University Of California, San Francisco · UG1 · FY2025 · EY
Basic and Translational Studies of Cystic Fibrosis
$1,038,005Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · DK
Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics
$1,037,792Faraz Choudhury · Immuto Scientific, Inc. · R44 · FY2022 · GM
The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: identifying causal mechanisms and therapeutic targets
$1,037,721Jeffrey Ivan Gordon · Washington University · R01 · FY2023 · DK
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
$1,037,671Sudha Seshadri · Boston University Medical Campus · UH2 · FY2016 · NS
STUDY OF WOMEN'S HEALTH ACROSS THE NATION (SWAN) V: UC DAVIS/KAISER
$1,037,314Ellen B Gold · University Of California At Davis · U01 · FY2018 · AG
Tissue Factor Antagonists for ALI/ARDS
$1,037,283Jack Owen Egan · Altor Bioscience. Llc · R44 · FY2006 · HL
Cellular Biology Of Host/parasite Interactions
$1,037,098David (ted) Hackstadt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Cell plasticity in the origin of gastric carcinogenesis
$1,037,059Eunyoung Choi · Vanderbilt University Medical Center · R01 · FY2022 · CA
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,037,049Richard A Cone · Mucommune, Llc · R44 · FY2024 · AI
Receptor Mediated Erythropoietin Metabolic Response
$1,036,882Constance Noguchi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
MOLECULAR BIOLOGY OF HEMORRHAGIC SHOCK
$1,036,751University Of Pittsburgh At Pittsburgh · P50 · FY2001 · GM
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD
$1,036,641Darren G Woodside · Aviara Pharmaceuticals, Inc. · R42 · FY2023 · DK
SBIR: In vivo validation and IND-enabling development of MM004, a bispecific inhaled immunotherapy for RSV and MPV
$1,036,484Richard A Cone · Mucommune, Llc · R44 · FY2023 · AI
Molecular Mechanism of TNF Signaling and Apoptosis
$1,036,383Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Rutgers Subproject
$1,036,123Donald R Gerecke · Univ Of Med/Dent Nj-R W Johnson Med Sch · U54 · FY2008 · AR